This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator.
The aim of this study is to determine the pharmacokinetics and pharmacodynamic characteristics of Ariva, Revel, Exalt and Stonewall (smokeless tobaccos), and compare these products to medicinal Commit nicotine lozenge.
Showing the most recent 10 out of 724 publications